Austin | UT Austin, BME5.202I Houston | BCM N1318 Dallas | UT Southwestern, NA 5.218 Texas A&M | ILSB3147
Biotech Development in Taiwan and Personal Experiences
Henry C. Liu, 劉朝瀚, Ph.D.
Vice Director, Lihpao Biomedical Lab at Taipei Veterans General Hospital
Dr. Liu works at Lihpao Life Corp., serving as Vice Director of Lihpao Biomedical Lab at Taipei Veterans General Hospital. As a project manager of clinical sequencing service and new drug development, he carries out several projects related to using genomic sequencing platform to identify biomarkers associated with disease prognosis, treatment outcome, and drug resistance. In the new drug development, he helps developing a platform for drug delivery, which is used to target against cancer and enzyme-deficient diseases with a cost-effective and oral delivery.
Henry Liu completed his Ph.D. in Bioengineering at UCSD under the guidance of Dr. Sanjay Nigam and Dr. Shu Chien, in which his main focus of study is the interaction between kidney functions and cellular metabolisms using methods of computational chemistry and data-mining. Prior to his Ph.D., Henry received B.S. degree in Bioengineering at UC Berkeley.